Drugs with verified catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

592 drugs/products referenced in verified catalyst events. Verified as of 2026-09-20.

Drug	Catalysts
KarXT	5
TPSAC	4
Litifilimab	3
Deucravacitinib	3
Povorcitinib	3
FDORA	3
ITRACONAZOLE	3
Sonrotoclax, Zanubrutinib	2
INCB099280	2
BHV-7000, BHV-7000	2
barzolvolimab, Matching placebo	2
INZ-701	2
Ruxolitinib Cream, Vehicle Cream	2
Apalutamide, Androgen-deprivation Therapy (ADT)	2
Itepekimab (SAR440340), Mometasone furoate nasal spray (MFNS)	2
Nemolizumab	2
Odevixibat	2
LP352	2
IMU-838 tablets	2
Leniolisib	2
Tirzepatide	2
Tobevibart, Elebsiran, Bulevirtide	2
Satralizumab	2
Investigational varicella vaccine, Marketed varicella vaccine, Measles, mumps, and rubella vaccine, Hepatitis A vaccine	2
TAK-360	2
Kedrion IVIG 10%	2
APG-157	2
RLS-0071	2
Artesunate ointment	2
Ebselen	2
Solriamfetol 150 mg, Solriamfetol 300 mg	2
PCV21, 20vPCV	2
ENV-294	2
Corabotase	2
SAR442970	2
QRX003, 4% Lotion	2
Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%, Vehicle containing excipients only (VEH) without active ingredient, Blue Light Photodynamic Therapy Illuminator device, BLU-U® model 4170E	2
PRIMAQUINE PHOSPHATE	2
CARBIDOPA AND LEVODOPA	2
COVID	2
CardiolRx	1
T3011, T3011 + pembrolizumab	1
mRNA-1403, mRNA-1405	1
PF-07220060, Letrozole, Fulvestrant, Midazolam	1
YTB323	1
AT02	1
OCU410ST	1
Sonelokimab	1
Depemokimab, Mepolizumab	1
Amlitelimab	1
NaBen®	1
BI-1206, Rituximab, Acalabrutinib	1
Oral repotrectinib (TPX-0005)	1
Linerixibat	1
Entrectinib, Crizotinib	1
Staccato alprazolam	1
Zanidatamab, Tislelizumab, Trastuzumab, Capecitabine	1
Durvalumab, Oleclumab, Monalizumab	1
JDQ443, trametinib, Ribociclib, cetuximab	1
JIN-A02	1
Adagrasib oral dose of 400 mg twice daily tablets, Pembrolizumab, Chemotherapy: Pemetrexed, Cisplatin/Carboplatin	1
Lu AG13909	1
OM-85	1
BMS-986449, Nivolumab	1
Azeliragon	1
AMT-162	1
SP-002, Vismodegib	1
Ifinatamab deruxtecan, Atezolizumab, Carboplatin	1
Dato-DXd, Osimertinib, Pemetrexed, Carboplatin	1
Biological: Solrikitug low dose, Biological: Solrikitug high dose	1
HS-20093, Topotecan	1
RSVPreF3 OA vaccine	1
Ranibizumab, EYE103	1
Neflamapimod	1
balinatunfib, balinatunfib-matching placebo	1
ARO-DIMERPA	1
DSP107 + Atezolizumab, Fruquintinib	1
sodium monofluorophosphate toothpaste	1
Sernova Cell Pouch	1
Baricitinib, Tocilizumab	1
Brenetafusp, Brenetafusp and pembrolizumab, Brenetafusp and chemotherapy, Brenetafusp and monoclonal antibodies and chemotherapy	1
VV1, Cemiplimab	1
LAM561	1
efgartigimod PH20 SC	1
Pirtobrutinib, Venetoclax, Rituximab	1
[O-15]-Water PET Myocardial Perfusion Imaging (MPI)	1
tapinarof cream, 1%	1
Iptacopan (LNP023)	1
Dazucorilant 300 mg, Dazucorilant 150 mg, Dazucorilant	1
ABBV-RGX-314 Dose 1, ABBV-RGX-314 Dose 2, Aflibercept (EYLEA®)	1
Afamitresgene autoleucel	1
XEN1101	1
GEn-1124	1
atumelnant	1
PRV211 (Intraoperative Cisplatin System), PRV111 (Cisplatin Transmucosal System), PRV131 (Cisplatin Intratumoral Injectable)	1
Futibatinib, Pembrolizumab, Cisplatin, 5-FU	1
YL201 for Injection	1
Xanamem	1
Debio 4326	1
Ziltivekimab	1
Retatrutide	1
sabirnetug	1
ENV-101	1
Maralixibat	1
EYP-1901, Aflibercept (2.0 mg)	1
ALD-102 Solution	1
Vonoprazan	1
IMVT-1402	1
iloperidone	1
N-803 (IL-15 Superagonist)	1
NVD003, Iliac Crest Bone Graft	1
TRIV-509	1
KYN-5356 low dose, KYN-5356 Medium Dose, KYN-5356 High Dose	1
CDI-988, Snow Mountain Virus	1
NT 201, NT 201 Placebo	1
Tacrolimus ophthalmic solution	1
QLS-111 Ophthalmic Solution (0.015%), QLS-111 Ophthalmic Solution (0.075%)	1
DISC-0974	1
HP-211	1
Preservative Free Polyethylene glycol 400 0.25%, Propylene Glycol (0.6%), Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%	1
AGN-151586	1
Risdiplam	1
186RNL	1
TAK-861	1
Pacritinib, Physician's Choice medications	1
mRNA-1189	1
rozanolixizumab	1
BMS-986278, BMS-986278 Placebo	1
Dupilumab	1
AZD6489, Licensed RSV vaccine #1, Licensed RSV vaccine #2	1
Tobemstomig, Tiragolumab, Pembrolizumab, Axitinib	1
HDM1002 200 mg, HDM1002 400 mg	1
Ravulizumab, Pozelimab, Cemdisiran, Eculizumab	1
CC-92480, Tazemetostat, BMS-986158, Trametinib	1
AAV9 BBP-812	1
DWN12088	1
Cobolimab, Dostarlimab	1
SGT-001	1
Oregovomab, Paclitaxel, Carboplatin	1
Milvexian	1
EC-104 high dose, EC-104 low dose, Dexamethasone intravitreal implant	1
AAA617, ARPI: Abiraterone, ARPI: Enzalutamide	1
ECC4703, Semaglutide	1
Glofitamab, Atezolizumab, Obinutuzumab, Tocilizumab	1
Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes, China Import (dapagliflozin) + China Import (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes	1
Benralizumab	1
Tobemstomig, Pembrolizumab, Nab-Paclitaxel	1
PF-07275315, PF-07264660	1
DS-3939a	1
Tralokinumab + TCS	1
Faricimab	1
SEP-363856	1
Ocrelizumab	1
Belzutifan, Palbociclib	1
Dazodalibep	1
Durvalumab, Tremelimumab, Pemetrexed, Pembrolizumab	1
Inclisiran sodium 300 mg	1
Volrustomig, Bevacizumab, Lenvatinib, Rilvegostomig	1
RO7204239, Risdiplam	1
Belzutifan, Pembrolizumab	1
BI 771716, Pegcetacoplan	1
Ianalumab, Corticosteroids	1
Pasireotide Diaspartate	1
venglustat (GZ402671), imiglucerase	1
GAd-209-FSP low dose, MVA-209-FSP low dose, GAd-209-FSP high dose, MVA-209-FSP high dose	1
Encorafenib, Binimetinib, Pembrolizumab	1
Afuresertib, Afuresertib/placebo	1
VX-121/TEZ/D-IVA	1
Adagrasib	1
TSN1611, TSN1611, TSN1611, TSN1611	1
AS1986NS	1
18F-metaFluorobenzylguanidine, Rubidium-82	1
18F-MFBG	1
TAK-788	1
ODM-208, Midazolam	1
Eteplirsen	1
TAK-788, Pemetrexed, Cisplatin, Carboplatin	1
ADG126, Pembrolizumab (KEYTRUDA®)	1
AB-1002	1
Palazestrant, Fulvestrant, Anastrozole, Letrozole	1
TEV-56248, Albuterol sulfate	1
JK07	1
Vonaprument	1
Venetoclax, cBTKi Monotherapy	1
anvumetostat	1
Setmelanotide	1
SPY002-072	1
MT-125	1
Ublituximab, Ublituximab	1
KH-001 ODT	1
FB-301, Chlorhexidine (0.5%) Vaginal Cleanse	1
Tuspetinib, Venetoclax Oral Tablet, Azacitidine for Intravenous Infusion	1
RO7198457 intravenous (IV), Observational group (no intervention)	1
Pyridoxal Phosphate	1
BBP-418	1
Venetoclax, Obinutuzumab	1
Sonrotoclax, Dexamethasone, Carfilzomib, Daratumumab	1
Tacabrutideg	1
CAM2029, Octreotide LAR, Lanreotide ATG	1
Clemizole HCl	1
Xcopri	1
Obicetrapib	1
Mirvetuximab soravtansine, Carboplatin	1
ABT-101	1
TYRA-300	1
Elacestrant	1
(Z)-endoxifen, goserelin	1
Apitegromab	1
FBX-101	1
Budigalimab, Livmoniplimab, Lenvatinib, Sorafenib	1
Onvansertib, FOLFIRI, Bevacizumab, FOLFOX	1
YL202 should be intravenously infused	1
Cretostimogene Grenadenorepvec, n-dodecyl-B-D-maltoside	1
XTMAB-16	1
RCT2100, RCT2100, RCT2100, Ivacaftor	1
Empasiprubart IV	1
FNP-223	1
APG777	1
obicetrapib 10 mg + obicetrapib/evolocumab 140 mg Q 2 weeks	1
CRB-601 monoclonal antibody, Anti-PD-1 monoclonal antibody	1
Retatrutide, Tirzepatide	1
CAL101	1
Tirbanibulin ointment 1%	1
ALKS 2680	1
ABBV-932, Antidepressant Therapy (ADT)	1
CYB704, Ocrevus-EU, Ocrevus-US	1
Enekinragene Inzadenovec (PCRX-201)	1
Tibulizumab Dose A, Tibulizumab Dose B	1
RE104 for Injection	1
DBV712 250 mcg	1
AR882 75 mg, XOI Low Dose, XOI High Dose	1
LY3938577, Degludec	1
LY4515100	1
Colgate SNaP Total 10/10, 1.5 Taurate, Colgate Great Regular Flavor Toothpaste, Flat Trimmed Extra Clean TB	1
Dostarlimab	1
Anifrolumab	1
cemiplimab, Fixed Dose Combination (FDC) cemiplimab+fianlimab	1
LOU064 (blinded)	1
Fitusiran	1
dabrafenib, trametinib	1
Parsaclisib, parsaclisib + itacitinib, parsaclisib + ruxolitinib, parsaclisib + ibrutinib	1
pembrolizumab, doxorubicin, vinblastine, dacarbazine	1
Pembrolizumab, Dostarlimab, Belrestotug, Nelistotug	1
Trastuzumab deruxtecan, Taxane, Pertuzumab, Trastuzumab	1
PRGN-2009 plus Pembrolizumab	1
REGN7075, Cemiplimab, Platinum-based doublet chemotherapy, Bevacizumab	1
Inavolisib, Fulvestrant, Alpelisib, Bupropion	1
Olatorepatide	1
Metaxalone 640 mg Oral Tablet	1
PA5108 Ocular Implant low dose, PA5108 Ocular Implant, high dose, Latanoprost 0.005% Ophthalmic Solution	1
Zilucoplan	1
AZD0901, 5-Fluorouracil, Leucovorin, l-leucovorin	1
Efanesoctocog alfa	1
ETOPOSIDE - Usual, ETOPOSIDE - Study	1
Abiraterone - Usual, Abiraterone - Study	1
ALECENSA - alectinib hydrochloride capsule	1
SMS001	1
NVX-CoV2705	1
RO7269162	1
JNJ-95597528	1
Pembrolizumab, Carboplatin, Paclitaxel, Docetaxel	1
povorcitinib, ICS-LABA	1
Nimacimab injection, Nimacimab placebo injection, semaglutide injection, Nimacimab 300 mg injection	1
Dostarlimab, CAPEOX	1
AZD0754, AZD2287	1
TX000045- Dose A, TX000045- Dose B	1
Dostarlimab, Carboplatin, Paclitaxel, Niraparib	1
RO7795081, Semaglutide	1
TB006	1
Rimegepant, Rimegepant	1
Perillyl alcohol	1
CC-92480, Bortezomib, Dexamethasone, Daratumumab	1
Alectinib, Entrectinib, Vemurafenib, Cobimetinib	1
Anvumetostat, Docetaxel, Comparator Anvumetostat Test Tablet	1
mRNA-3745	1
AVTX-803 (L-Fucose)	1
ONC-392 low, ONC-392 high, lutetium Lu 177 vipivotide tetraxetan	1
AAV9-hSyn1-miGRIK2	1
AU-011, SCS Microinjector, Laser	1
D-0502, Fulvestrant	1
ARV-806	1
Jynneos, MVA-BN (Quail)	1
rilzabrutinib	1
SL1002, Normal Saline	1
MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN)	1
VRB-101	1
Oral BGE-102, Oral Placebo Matching BGE-102	1
KarXT, Trimethobenzamide, Ondansetron, Meclizine	1
Selinexor, Selinexor, Selinexor	1
LUM015, LUM 2.6 Imaging Device	1
ACIT-1	1
Eluxadoline	1
relacorilant	1
Ralinepag	1
T89 capsule	1
Ruvidar® (TLD-1433) bladder infusion and PDT	1
BRTX-100, Saline	1
PMD-026, fulvestrant	1
ALK-001	1
Low Dose Budesonide, High Dose Budesonide	1
Selinexor (combination therapy), Selinexor (combination therapy), Selinexor (combination therapy), Rituximab (combination therapy)	1
PRL3-zumab	1
ST101, Temozolomide, Radiation	1
RPESC-RPE-4W	1
AdAPT-001, Checkpoint Inhibitor, Immune	1
ABBV-RGX-314, ABBV-RGX-314, Ranibizumab (LUCENTIS®)	1
ARX788	1
Atenativ	1
ZEN003694, Enzalutamide	1
Recombinant human tissue kallikrein	1
azenosertib	1
HEC585 dose A, HEC585 dose B	1
CR6086, AGEN2034	1
DNL593	1
Ensifentrine	1
olvimulogene nanivacirepvec, Platinum chemotherapy: carboplatin (preferred) or cisplatin, Non-platinum chemotherapy: Physician's Choice of gemcitabine, taxane (paclitaxel, docetaxel or nab-paclitaxel) or pegylated liposomal doxorubicin, Bevacizumab (or biosimilar)	1
Elacestrant, Abemaciclib	1
Donidalorsen	1
anitocabtagene-autoleucel	1
Masupirdine 50 mg, Masupirdine 100 mg	1
Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory	1
Evexomostat	1
LP-300, Pemetrexed, Carboplatin	1
STP938	1
AP203, AP203	1
DR-01	1
RYZ101, Everolimus, Sunitinib, Octreotide	1
Resmetirom	1
TVI-Brain-1, Radiotherapy, Temozolomide	1
AMDX-2011P	1
TAS-120	1
A2B530, xT-Onco with HLA-LOH Assay	1
ZT-01, 7 mg, ZT-01, 15 mg, ZT-01, 22 mg	1
Iltamiocel	1
TU2218 + KEYTRUDA® (Pembrolizumab)	1
TARA-002	1
BEAM-201	1
ALTO-300	1
CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs), Diagnostic Catheterization	1
Tinengotinib 8 mg, Tinengotinib 10 mg, Physician's Choice	1
nab-sirolimus	1
MNV-201	1
Descartes-08	1
NS-229	1
BN104 monotherapy, BN104 monotherapy, BN104 monotherapy - rp2d	1
RABI-767	1
NXC-201 CAR-T	1
ABBV-400, Bevacizumab, Folinic Acid, Fluorouracil	1
LX2020	1
BHV-7000, BHV-7000, BHV-7000	1
SNK01	1
AT-1965 Liposome Injection	1
EIK1001, Pembrolizumab, Paclitaxel, Pemetrexed	1
MT218 injection	1
ZILRETTA	1
Seralutinib, Gereic Dry Powder Inhaler	1
LAT010, LAT010 + ICI	1
STIMULAN VG	1
OMS906 study drug	1
WGI-0301 at MTD/RP2D dose IV infusion, QW, WGI-0301 at MTD/RP2D -1 dose IV infusion, QW, Sorafenib 400 mg PO, BID continuously, Sorafenib 400 mg PO, BID	1
OCTA-C1-INH	1
ETX-19477	1
NoNO-42	1
NMD670	1
BO-112	1
GIM-531, Anti-PD-1 monoclonal antibody	1
RSLV-132	1
Obefazimod	1
Lutikizumab	1
ADI-270, Fludarabine, Cyclophosphamide	1
BRII-179, BRII-835 (VIR-2218), PEG-IFNα	1
Claseprubart	1
EscharEx (EX-03)	1
AGA2118	1
SA53-OS (phase 1), SA53-OS (phase 2)	1
SHJ002, Atropine	1
Budesonide	1
Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab, Trifluridine-tipiracil plus Bevacizumab Alone	1
RNK08954-01	1
Felzartamab	1
TR987 0.1% gel + Standard of Care	1
Crofelemer Powder for Oral Solution	1
ORX750	1
CNP-103	1
Stem cell, Genetic Screening, Genetic Reprogramming, Cell Maturation	1
navenibart	1
Halneuron, Halneuron (Open Label Extension)	1
d-MAPPS, PI and Patient Masked	1
Pandemic flu H5 HA mRNA SD2 vaccine	1
human retinal progenitor cells, Mock injection	1
VDPHL01	1
KB801	1
1.0mg/kg/day PRAX-562, 1.5mg/kg/day PRAX-562	1
KB803	1
1mg elsunersen, 0.5mg elsunersen	1
Ninerafaxstat 200mg MR	1
EC5026 oral tablet	1
LY3537021, Background Chemotherapy	1
EL219, Active Comparator- IV Antifungal (LAmB or voriconazole)	1
VQW-765	1